Pharma & Healthcare
Global Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 06, 25
- ID: 288749
- Pages: 151
- Figures: 155
- Views: 28
In 2024, the global market size of Vaccines was estimated to be worth US$ 50450 million and is forecast to reach approximately US$ 73490 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines.
The Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segment by Application
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines.
The Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segment by Application
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Rabies vaccine
1.3.3 Influenza vaccine
1.3.4 HPV vaccine
1.3.5 Hepatitis B
1.3.6 Hepatitis A
1.3.7 Leprosy vaccine
1.3.8 Polio vaccine
1.3.9 JE vaccine
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines Market Size Estimates and Forecasts
2.1.1 Global Vaccines Revenue 2020-2031
2.1.2 Global Vaccines Sales 2020-2031
2.2 Vaccines Market Size by Region: 2024 Versus 2031
2.3 Vaccines Sales by Region (2020-2031)
2.3.1 Global Vaccines Sales by Region: 2020-2025
2.3.2 Global Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Vaccines Sales Market Share by Region (2020-2031)
2.4 Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Vaccines Revenue by Region: 2020-2025
2.4.2 Global Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Recombinant Vaccines of Vaccines Revenue Market Share by Application
3.3.2 Viral Vaccines of Vaccines Revenue Market Share by Application
3.3.3 Polysaccharide Vaccines of Vaccines Revenue Market Share by Application
3.3.4 Others of Vaccines Revenue Market Share by Application
4 Global Vaccines by Manufacturers
4.1 Global Top Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Vaccines Market
4.5.3 Manufacturers Vaccines Product Type and Application
4.5.4 Recombinant Vaccines Market Sales of Vaccines by Manufacturer
4.5.5 Viral Vaccines Market Sales of Vaccines by Manufacturer
4.5.6 Polysaccharide Vaccines Market Sales of Vaccines by Manufacturer
4.5.7 Others Market Sales of Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 GSK
5.1.1 GSK Company Information
5.1.2 GSK Description, Business Overview
5.1.3 GSK Vaccines Products Offered
5.1.4 GSK Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 GSK Vaccines Sales by Product in 2024
5.1.6 GSK Vaccines Sales by Application in 2024
5.1.7 GSK Vaccines Sales by Geographic Area in 2024
5.1.8 GSK Recent Developments
5.2 Sanofi
5.2.1 Sanofi Company Information
5.2.2 Sanofi Description, Business Overview
5.2.3 Sanofi Vaccines Products Offered
5.2.4 Sanofi Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sanofi Vaccines Sales by Product in 2024
5.2.6 Sanofi Vaccines Sales by Application in 2024
5.2.7 Sanofi Vaccines Sales by Geographic Area in 2024
5.2.8 Sanofi Recent Developments
5.3 Merck
5.3.1 Merck Company Information
5.3.2 Merck Description, Business Overview
5.3.3 Merck Vaccines Products Offered
5.3.4 Merck Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Merck Vaccines Sales by Product in 2024
5.3.6 Merck Vaccines Sales by Application in 2024
5.3.7 Merck Vaccines Sales by Geographic Area in 2024
5.3.8 Merck Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Vaccines Products Offered
5.4.4 Pfizer Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Vaccines Sales by Product in 2024
5.4.6 Pfizer Vaccines Sales by Application in 2024
5.4.7 Pfizer Vaccines Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 Novartis(GSK)
5.5.1 Novartis(GSK) Company Information
5.5.2 Novartis(GSK) Description, Business Overview
5.5.3 Novartis(GSK) Vaccines Products Offered
5.5.4 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Novartis(GSK) Vaccines Sales by Product in 2024
5.5.6 Novartis(GSK) Vaccines Sales by Application in 2024
5.5.7 Novartis(GSK) Vaccines Sales by Geographic Area in 2024
5.5.8 Novartis(GSK) Recent Developments
5.6 CSL
5.6.1 CSL Company Information
5.6.2 CSL Description, Business Overview
5.6.3 CSL Vaccines Products Offered
5.6.4 CSL Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 CSL Vaccines Sales by Product in 2024
5.6.6 CSL Vaccines Sales by Application in 2024
5.6.7 CSL Vaccines Sales by Geographic Area in 2024
5.6.8 CSL Recent Developments
5.7 MedImmune LLC
5.7.1 MedImmune LLC Company Information
5.7.2 MedImmune LLC Description, Business Overview
5.7.3 MedImmune LLC Vaccines Products Offered
5.7.4 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 MedImmune LLC Vaccines Sales by Product in 2024
5.7.6 MedImmune LLC Vaccines Sales by Application in 2024
5.7.7 MedImmune LLC Vaccines Sales by Geographic Area in 2024
5.7.8 MedImmune LLC Recent Developments
5.8 J&J(Crucell)
5.8.1 J&J(Crucell) Company Information
5.8.2 J&J(Crucell) Description, Business Overview
5.8.3 J&J(Crucell) Vaccines Products Offered
5.8.4 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 J&J(Crucell) Vaccines Sales by Product in 2024
5.8.6 J&J(Crucell) Vaccines Sales by Application in 2024
5.8.7 J&J(Crucell) Vaccines Sales by Geographic Area in 2024
5.8.8 J&J(Crucell) Recent Developments
5.9 China National Biotec
5.9.1 China National Biotec Company Information
5.9.2 China National Biotec Description, Business Overview
5.9.3 China National Biotec Vaccines Products Offered
5.9.4 China National Biotec Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 China National Biotec Vaccines Sales by Product in 2024
5.9.6 China National Biotec Vaccines Sales by Application in 2024
5.9.7 China National Biotec Vaccines Sales by Geographic Area in 2024
5.9.8 China National Biotec Recent Developments
5.10 Tiantan
5.10.1 Tiantan Company Information
5.10.2 Tiantan Description, Business Overview
5.10.3 Tiantan Vaccines Products Offered
5.10.4 Tiantan Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Tiantan Vaccines Sales by Product in 2024
5.10.6 Tiantan Vaccines Sales by Application in 2024
5.10.7 Tiantan Vaccines Sales by Geographic Area in 2024
5.10.8 Tiantan Recent Developments
5.11 Hualan
5.11.1 Hualan Company Information
5.11.2 Hualan Description, Business Overview
5.11.3 Hualan Vaccines Products Offered
5.11.4 Hualan Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Hualan Vaccines Sales by Product in 2024
5.11.6 Hualan Vaccines Sales by Application in 2024
5.11.7 Hualan Vaccines Sales by Geographic Area in 2024
5.11.8 Hualan Recent Developments
5.12 Kangtai
5.12.1 Kangtai Company Information
5.12.2 Kangtai Description, Business Overview
5.12.3 Kangtai Vaccines Products Offered
5.12.4 Kangtai Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Kangtai Vaccines Sales by Product in 2024
5.12.6 Kangtai Vaccines Sales by Application in 2024
5.12.7 Kangtai Vaccines Sales by Geographic Area in 2024
5.12.8 Kangtai Recent Developments
5.13 Hissen
5.13.1 Hissen Company Information
5.13.2 Hissen Description, Business Overview
5.13.3 Hissen Vaccines Products Offered
5.13.4 Hissen Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Hissen Vaccines Sales by Product in 2024
5.13.6 Hissen Vaccines Sales by Application in 2024
5.13.7 Hissen Vaccines Sales by Geographic Area in 2024
5.13.8 Hissen Recent Developments
5.14 Jintan
5.14.1 Jintan Company Information
5.14.2 Jintan Description, Business Overview
5.14.3 Jintan Vaccines Products Offered
5.14.4 Jintan Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Jintan Vaccines Sales by Product in 2024
5.14.6 Jintan Vaccines Sales by Application in 2024
5.14.7 Jintan Vaccines Sales by Geographic Area in 2024
5.14.8 Jintan Recent Developments
6 North America
6.1 North America Vaccines Market Size YoY Growth 2020-2031
6.2 North America Vaccines Market Facts & Figures by Country
6.2.1 North America Vaccines Sales by Country (2020-2031)
6.2.2 North America Vaccines Revenue by Country (2020-2031)
6.3 North America Vaccines Sales by Type (2020-2025)
6.4 North America Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Vaccines Market Facts & Figures by Country
8.2.1 Europe Vaccines Sales by Country (2020-2031)
8.2.2 Europe Vaccines Revenue by Country (2020-2031)
8.3 Europe Vaccines Sales by Type (2020-2025)
8.4 Europe Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Vaccines Market Facts & Figures by Country
9.2.1 Latin America Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Vaccines Revenue by Country (2020-2031)
9.3 Latin America Vaccines Sales by Type (2020-2025)
9.4 Latin America Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Vaccines Supply Chain Analysis
11.2 Vaccines Key Raw Materials and Upstream Suppliers
11.3 Vaccines Clients Analysis
11.4 Vaccines Sales Channel and Sales Model Analysis
11.4.1 Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Vaccines Distributors
12 Vaccines Market Dynamics
12.1 Vaccines Industry Trends
12.2 Vaccines Market Drivers
12.3 Vaccines Market Challenges
12.4 Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Rabies vaccine
1.3.3 Influenza vaccine
1.3.4 HPV vaccine
1.3.5 Hepatitis B
1.3.6 Hepatitis A
1.3.7 Leprosy vaccine
1.3.8 Polio vaccine
1.3.9 JE vaccine
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines Market Size Estimates and Forecasts
2.1.1 Global Vaccines Revenue 2020-2031
2.1.2 Global Vaccines Sales 2020-2031
2.2 Vaccines Market Size by Region: 2024 Versus 2031
2.3 Vaccines Sales by Region (2020-2031)
2.3.1 Global Vaccines Sales by Region: 2020-2025
2.3.2 Global Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Vaccines Sales Market Share by Region (2020-2031)
2.4 Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Vaccines Revenue by Region: 2020-2025
2.4.2 Global Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Recombinant Vaccines of Vaccines Revenue Market Share by Application
3.3.2 Viral Vaccines of Vaccines Revenue Market Share by Application
3.3.3 Polysaccharide Vaccines of Vaccines Revenue Market Share by Application
3.3.4 Others of Vaccines Revenue Market Share by Application
4 Global Vaccines by Manufacturers
4.1 Global Top Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Vaccines Market
4.5.3 Manufacturers Vaccines Product Type and Application
4.5.4 Recombinant Vaccines Market Sales of Vaccines by Manufacturer
4.5.5 Viral Vaccines Market Sales of Vaccines by Manufacturer
4.5.6 Polysaccharide Vaccines Market Sales of Vaccines by Manufacturer
4.5.7 Others Market Sales of Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 GSK
5.1.1 GSK Company Information
5.1.2 GSK Description, Business Overview
5.1.3 GSK Vaccines Products Offered
5.1.4 GSK Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 GSK Vaccines Sales by Product in 2024
5.1.6 GSK Vaccines Sales by Application in 2024
5.1.7 GSK Vaccines Sales by Geographic Area in 2024
5.1.8 GSK Recent Developments
5.2 Sanofi
5.2.1 Sanofi Company Information
5.2.2 Sanofi Description, Business Overview
5.2.3 Sanofi Vaccines Products Offered
5.2.4 Sanofi Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sanofi Vaccines Sales by Product in 2024
5.2.6 Sanofi Vaccines Sales by Application in 2024
5.2.7 Sanofi Vaccines Sales by Geographic Area in 2024
5.2.8 Sanofi Recent Developments
5.3 Merck
5.3.1 Merck Company Information
5.3.2 Merck Description, Business Overview
5.3.3 Merck Vaccines Products Offered
5.3.4 Merck Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Merck Vaccines Sales by Product in 2024
5.3.6 Merck Vaccines Sales by Application in 2024
5.3.7 Merck Vaccines Sales by Geographic Area in 2024
5.3.8 Merck Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Vaccines Products Offered
5.4.4 Pfizer Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Vaccines Sales by Product in 2024
5.4.6 Pfizer Vaccines Sales by Application in 2024
5.4.7 Pfizer Vaccines Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 Novartis(GSK)
5.5.1 Novartis(GSK) Company Information
5.5.2 Novartis(GSK) Description, Business Overview
5.5.3 Novartis(GSK) Vaccines Products Offered
5.5.4 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Novartis(GSK) Vaccines Sales by Product in 2024
5.5.6 Novartis(GSK) Vaccines Sales by Application in 2024
5.5.7 Novartis(GSK) Vaccines Sales by Geographic Area in 2024
5.5.8 Novartis(GSK) Recent Developments
5.6 CSL
5.6.1 CSL Company Information
5.6.2 CSL Description, Business Overview
5.6.3 CSL Vaccines Products Offered
5.6.4 CSL Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 CSL Vaccines Sales by Product in 2024
5.6.6 CSL Vaccines Sales by Application in 2024
5.6.7 CSL Vaccines Sales by Geographic Area in 2024
5.6.8 CSL Recent Developments
5.7 MedImmune LLC
5.7.1 MedImmune LLC Company Information
5.7.2 MedImmune LLC Description, Business Overview
5.7.3 MedImmune LLC Vaccines Products Offered
5.7.4 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 MedImmune LLC Vaccines Sales by Product in 2024
5.7.6 MedImmune LLC Vaccines Sales by Application in 2024
5.7.7 MedImmune LLC Vaccines Sales by Geographic Area in 2024
5.7.8 MedImmune LLC Recent Developments
5.8 J&J(Crucell)
5.8.1 J&J(Crucell) Company Information
5.8.2 J&J(Crucell) Description, Business Overview
5.8.3 J&J(Crucell) Vaccines Products Offered
5.8.4 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 J&J(Crucell) Vaccines Sales by Product in 2024
5.8.6 J&J(Crucell) Vaccines Sales by Application in 2024
5.8.7 J&J(Crucell) Vaccines Sales by Geographic Area in 2024
5.8.8 J&J(Crucell) Recent Developments
5.9 China National Biotec
5.9.1 China National Biotec Company Information
5.9.2 China National Biotec Description, Business Overview
5.9.3 China National Biotec Vaccines Products Offered
5.9.4 China National Biotec Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 China National Biotec Vaccines Sales by Product in 2024
5.9.6 China National Biotec Vaccines Sales by Application in 2024
5.9.7 China National Biotec Vaccines Sales by Geographic Area in 2024
5.9.8 China National Biotec Recent Developments
5.10 Tiantan
5.10.1 Tiantan Company Information
5.10.2 Tiantan Description, Business Overview
5.10.3 Tiantan Vaccines Products Offered
5.10.4 Tiantan Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Tiantan Vaccines Sales by Product in 2024
5.10.6 Tiantan Vaccines Sales by Application in 2024
5.10.7 Tiantan Vaccines Sales by Geographic Area in 2024
5.10.8 Tiantan Recent Developments
5.11 Hualan
5.11.1 Hualan Company Information
5.11.2 Hualan Description, Business Overview
5.11.3 Hualan Vaccines Products Offered
5.11.4 Hualan Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Hualan Vaccines Sales by Product in 2024
5.11.6 Hualan Vaccines Sales by Application in 2024
5.11.7 Hualan Vaccines Sales by Geographic Area in 2024
5.11.8 Hualan Recent Developments
5.12 Kangtai
5.12.1 Kangtai Company Information
5.12.2 Kangtai Description, Business Overview
5.12.3 Kangtai Vaccines Products Offered
5.12.4 Kangtai Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Kangtai Vaccines Sales by Product in 2024
5.12.6 Kangtai Vaccines Sales by Application in 2024
5.12.7 Kangtai Vaccines Sales by Geographic Area in 2024
5.12.8 Kangtai Recent Developments
5.13 Hissen
5.13.1 Hissen Company Information
5.13.2 Hissen Description, Business Overview
5.13.3 Hissen Vaccines Products Offered
5.13.4 Hissen Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Hissen Vaccines Sales by Product in 2024
5.13.6 Hissen Vaccines Sales by Application in 2024
5.13.7 Hissen Vaccines Sales by Geographic Area in 2024
5.13.8 Hissen Recent Developments
5.14 Jintan
5.14.1 Jintan Company Information
5.14.2 Jintan Description, Business Overview
5.14.3 Jintan Vaccines Products Offered
5.14.4 Jintan Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Jintan Vaccines Sales by Product in 2024
5.14.6 Jintan Vaccines Sales by Application in 2024
5.14.7 Jintan Vaccines Sales by Geographic Area in 2024
5.14.8 Jintan Recent Developments
6 North America
6.1 North America Vaccines Market Size YoY Growth 2020-2031
6.2 North America Vaccines Market Facts & Figures by Country
6.2.1 North America Vaccines Sales by Country (2020-2031)
6.2.2 North America Vaccines Revenue by Country (2020-2031)
6.3 North America Vaccines Sales by Type (2020-2025)
6.4 North America Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Vaccines Market Facts & Figures by Country
8.2.1 Europe Vaccines Sales by Country (2020-2031)
8.2.2 Europe Vaccines Revenue by Country (2020-2031)
8.3 Europe Vaccines Sales by Type (2020-2025)
8.4 Europe Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Vaccines Market Facts & Figures by Country
9.2.1 Latin America Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Vaccines Revenue by Country (2020-2031)
9.3 Latin America Vaccines Sales by Type (2020-2025)
9.4 Latin America Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Vaccines Supply Chain Analysis
11.2 Vaccines Key Raw Materials and Upstream Suppliers
11.3 Vaccines Clients Analysis
11.4 Vaccines Sales Channel and Sales Model Analysis
11.4.1 Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Vaccines Distributors
12 Vaccines Market Dynamics
12.1 Vaccines Industry Trends
12.2 Vaccines Market Drivers
12.3 Vaccines Market Challenges
12.4 Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Vaccines Sales by Region (2020-2025) & (K Units)
Table 5. Global Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Vaccines Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Vaccines Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Vaccines Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Vaccines Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Vaccines Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Vaccines Sales Share by Manufacturer (2020-2025)
Table 18. Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Vaccines Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Vaccines Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Vaccines Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines as of 2024)
Table 24. Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Vaccines Market
Table 26. Manufacturers Vaccines Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. GSK Company Information
Table 29. GSK Description and Business Overview
Table 30. GSK Vaccines Product
Table 31. GSK Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. GSK Sales Proportion of Vaccines by Product in 2024
Table 33. GSK Sales Proportion of Vaccines by Application in 2024
Table 34. GSK Sales Proportion of Vaccines by Geographic Area in 2024
Table 35. GSK Recent Developments
Table 36. Sanofi Company Information
Table 37. Sanofi Description and Business Overview
Table 38. Sanofi Vaccines Product
Table 39. Sanofi Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Sanofi Sales Proportion of Vaccines by Product in 2024
Table 41. Sanofi Sales Proportion of Vaccines by Application in 2024
Table 42. Sanofi Sales Proportion of Vaccines by Geographic Area in 2024
Table 43. Sanofi Recent Developments
Table 44. Merck Company Information
Table 45. Merck Description and Business Overview
Table 46. Merck Vaccines Product
Table 47. Merck Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Merck Sales Proportion of Vaccines by Product in 2024
Table 49. Merck Sales Proportion of Vaccines by Application in 2024
Table 50. Merck Sales Proportion of Vaccines by Geographic Area in 2024
Table 51. Merck Recent Developments
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Vaccines Product
Table 55. Pfizer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Pfizer Sales Proportion of Vaccines by Product in 2024
Table 57. Pfizer Sales Proportion of Vaccines by Application in 2024
Table 58. Pfizer Sales Proportion of Vaccines by Geographic Area in 2024
Table 59. Pfizer Recent Developments
Table 60. Novartis(GSK) Company Information
Table 61. Novartis(GSK) Description and Business Overview
Table 62. Novartis(GSK) Vaccines Product
Table 63. Novartis(GSK) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Novartis(GSK) Sales Proportion of Vaccines by Product in 2024
Table 65. Novartis(GSK) Sales Proportion of Vaccines by Application in 2024
Table 66. Novartis(GSK) Sales Proportion of Vaccines by Geographic Area in 2024
Table 67. Novartis(GSK) Recent Developments
Table 68. CSL Company Information
Table 69. CSL Description and Business Overview
Table 70. CSL Vaccines Product
Table 71. CSL Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. CSL Sales Proportion of Vaccines by Product in 2024
Table 73. CSL Sales Proportion of Vaccines by Application in 2024
Table 74. CSL Sales Proportion of Vaccines by Geographic Area in 2024
Table 75. CSL Recent Developments
Table 76. MedImmune LLC Company Information
Table 77. MedImmune LLC Description and Business Overview
Table 78. MedImmune LLC Vaccines Product
Table 79. MedImmune LLC Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. MedImmune LLC Sales Proportion of Vaccines by Product in 2024
Table 81. MedImmune LLC Sales Proportion of Vaccines by Application in 2024
Table 82. MedImmune LLC Sales Proportion of Vaccines by Geographic Area in 2024
Table 83. MedImmune LLC Recent Developments
Table 84. J&J(Crucell) Company Information
Table 85. J&J(Crucell) Description and Business Overview
Table 86. J&J(Crucell) Vaccines Product
Table 87. J&J(Crucell) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. J&J(Crucell) Sales Proportion of Vaccines by Product in 2024
Table 89. J&J(Crucell) Sales Proportion of Vaccines by Application in 2024
Table 90. J&J(Crucell) Sales Proportion of Vaccines by Geographic Area in 2024
Table 91. J&J(Crucell) Recent Developments
Table 92. China National Biotec Company Information
Table 93. China National Biotec Description and Business Overview
Table 94. China National Biotec Vaccines Product
Table 95. China National Biotec Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. China National Biotec Sales Proportion of Vaccines by Product in 2024
Table 97. China National Biotec Sales Proportion of Vaccines by Application in 2024
Table 98. China National Biotec Sales Proportion of Vaccines by Geographic Area in 2024
Table 99. China National Biotec Recent Developments
Table 100. Tiantan Company Information
Table 101. Tiantan Description and Business Overview
Table 102. Tiantan Vaccines Product
Table 103. Tiantan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Tiantan Sales Proportion of Vaccines by Product in 2024
Table 105. Tiantan Sales Proportion of Vaccines by Application in 2024
Table 106. Tiantan Sales Proportion of Vaccines by Geographic Area in 2024
Table 107. Tiantan Recent Developments
Table 108. Hualan Company Information
Table 109. Hualan Description and Business Overview
Table 110. Hualan Vaccines Product
Table 111. Hualan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Hualan Sales Proportion of Vaccines by Product in 2024
Table 113. Hualan Sales Proportion of Vaccines by Application in 2024
Table 114. Hualan Sales Proportion of Vaccines by Geographic Area in 2024
Table 115. Hualan Recent Developments
Table 116. Kangtai Company Information
Table 117. Kangtai Description and Business Overview
Table 118. Kangtai Vaccines Product
Table 119. Kangtai Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Kangtai Sales Proportion of Vaccines by Product in 2024
Table 121. Kangtai Sales Proportion of Vaccines by Application in 2024
Table 122. Kangtai Sales Proportion of Vaccines by Geographic Area in 2024
Table 123. Kangtai Recent Developments
Table 124. Hissen Company Information
Table 125. Hissen Description and Business Overview
Table 126. Hissen Vaccines Product
Table 127. Hissen Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Hissen Sales Proportion of Vaccines by Product in 2024
Table 129. Hissen Sales Proportion of Vaccines by Application in 2024
Table 130. Hissen Sales Proportion of Vaccines by Geographic Area in 2024
Table 131. Hissen Recent Developments
Table 132. Jintan Company Information
Table 133. Jintan Description and Business Overview
Table 134. Jintan Vaccines Product
Table 135. Jintan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Jintan Sales Proportion of Vaccines by Product in 2024
Table 137. Jintan Sales Proportion of Vaccines by Application in 2024
Table 138. Jintan Sales Proportion of Vaccines by Geographic Area in 2024
Table 139. Jintan Recent Developments
Table 140. North America Vaccines Sales by Country (2020-2025) & (K Units)
Table 141. North America Vaccines Sales by Country (2026-2031) & (K Units)
Table 142. North America Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 143. North America Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 144. North America Vaccines Sales by Type (2020-2025) & (K Units)
Table 145. North America Vaccines Sales by Application (2020-2025) & (K Units)
Table 146. Asia-Pacific Vaccines Sales by Region (2020-2025) & (K Units)
Table 147. Asia-Pacific Vaccines Sales by Region (2026-2031) & (K Units)
Table 148. Asia-Pacific Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 149. Asia-Pacific Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 150. Asia-Pacific Vaccines Sales by Type (2020-2025) & (K Units)
Table 151. Asia-Pacific Vaccines Sales by Application (2020-2025) & (K Units)
Table 152. Europe Vaccines Sales by Country (2020-2025) & (K Units)
Table 153. Europe Vaccines Sales by Country (2026-2031) & (K Units)
Table 154. Europe Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 155. Europe Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 156. Europe Vaccines Sales by Type (2020-2025) & (K Units)
Table 157. Europe Vaccines Sales by Application (2020-2025) & (K Units)
Table 158. Latin America Vaccines Sales by Country (2020-2025) & (K Units)
Table 159. Latin America Vaccines Sales by Country (2026-2031) & (K Units)
Table 160. Latin America Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 161. Latin America Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 162. Latin America Vaccines Sales by Type (2020-2025) & (K Units)
Table 163. Latin America Vaccines Sales by Application (2020-2025) & (K Units)
Table 164. Middle East and Africa Vaccines Sales by Country (2020-2025) & (K Units)
Table 165. Middle East and Africa Vaccines Sales by Country (2026-2031) & (K Units)
Table 166. Middle East and Africa Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 167. Middle East and Africa Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 168. Middle East and Africa Vaccines Sales by Type (2020-2025) & (K Units)
Table 169. Middle East and Africa Vaccines Sales by Application (2020-2025) & (K Units)
Table 170. Vaccines Key Raw Materials, Industry Status and Trend
Table 171. Vaccines Key Raw Materials and Upstream Suppliers
Table 172. Vaccines Clients Status and Trend
Table 173. Vaccines Typical Clients
Table 174. Vaccines Distributors
Table 175. Vaccines Market Trends
Table 176. Vaccines Market Drivers
Table 177. Vaccines Market Challenges
Table 178. Vaccines Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
Table 182. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Vaccines Product Picture
Figure 2. Global Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. Recombinant Vaccines Product Picture
Figure 5. Viral Vaccines Product Picture
Figure 6. Polysaccharide Vaccines Product Picture
Figure 7. Others Product Picture
Figure 8. Global Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Vaccines Sales Market Share by Application in 2024 & 2031
Figure 10. Rabies vaccine
Figure 11. Influenza vaccine
Figure 12. HPV vaccine
Figure 13. Hepatitis B
Figure 14. Hepatitis A
Figure 15. Leprosy vaccine
Figure 16. Polio vaccine
Figure 17. JE vaccine
Figure 18. Others
Figure 19. Vaccines Report Years Considered
Figure 20. Global Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Vaccines Market Size 2020-2031 (US$ Million)
Figure 22. Global Vaccines Sales 2020-2031 (K Units)
Figure 23. Global Vaccines Sales Market Share Forecast by Region (2020-2031)
Figure 24. Global Vaccines Revenue Market Share by Region (2020-2031)
Figure 25. Global Vaccines Sales Market Share Forecast by Type (2020-2031)
Figure 26. Global Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 27. Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 28. Global Vaccines Sales Market Share Forecast by Application (2020-2031)
Figure 29. Global Vaccines Revenue Market Share Forecast by Application (2020-2031)
Figure 30. Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 31. Recombinant Vaccines of Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 32. Viral Vaccines of Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 33. Polysaccharide Vaccines of Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 34. Others of Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 35. Global Vaccines Sales Share by Manufacturer in 2024
Figure 36. Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Recombinant Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 38. Viral Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 39. Polysaccharide Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 40. Others Market Sales Proportion by Manufacturer in 2024
Figure 41. North America Vaccines Revenue 2020-2031 (US$ Million)
Figure 42. North America Vaccines Sales Market Share by Type (2020-2025)
Figure 43. North America Vaccines Sales Market Share by Application (2020-2025)
Figure 44. Asia-Pacific Vaccines Revenue 2020-2031 (US$ Million)
Figure 45. Asia-Pacific Vaccines Sales Market Share by Region (2020-2031)
Figure 46. Asia-Pacific Vaccines Revenue Market Share by Region (2020-2031)
Figure 47. Asia-Pacific Vaccines Sales Market Share by Type (2020-2025)
Figure 48. Asia-Pacific Vaccines Sales Market Share by Application (2020-2025)
Figure 49. Europe Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Europe Vaccines Sales Market Share by Country (2020-2031)
Figure 51. Europe Vaccines Revenue Market Share by Country (2020-2031)
Figure 52. Europe Vaccines Sales Market Share by Type (2020-2025)
Figure 53. Europe Vaccines Sales Market Share by Application (2020-2025)
Figure 54. Latin America Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 55. Latin America Vaccines Sales Market Share by Country (2020-2031)
Figure 56. Latin America Vaccines Revenue Market Share by Country (2020-2025)
Figure 57. Latin America Vaccines Sales Market Share by Type (2020-2025)
Figure 58. Latin America Vaccines Sales Market Share by Application (2020-2025)
Figure 59. Middle East and Africa Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 60. Middle East and Africa Vaccines Sales Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Vaccines Revenue Market Share by Country (2020-2031)
Figure 62. Middle East and Africa Vaccines Sales Market Share by Type (2020-2025)
Figure 63. Middle East and Africa Vaccines Sales Market Share by Application (2020-2025)
Figure 64. Vaccines Supply Chain (Upstream and Downstream Market)
Figure 65. Global Production Market Share of Vaccines Raw Materials by Region in 2024
Figure 66. Vaccines Distribution Channels
Figure 67. Global Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 68. Global Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Vaccines Sales by Region (2020-2025) & (K Units)
Table 5. Global Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Vaccines Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Vaccines Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Vaccines Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Vaccines Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Vaccines Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Vaccines Sales Share by Manufacturer (2020-2025)
Table 18. Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Vaccines Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Vaccines Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Vaccines Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines as of 2024)
Table 24. Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Vaccines Market
Table 26. Manufacturers Vaccines Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. GSK Company Information
Table 29. GSK Description and Business Overview
Table 30. GSK Vaccines Product
Table 31. GSK Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. GSK Sales Proportion of Vaccines by Product in 2024
Table 33. GSK Sales Proportion of Vaccines by Application in 2024
Table 34. GSK Sales Proportion of Vaccines by Geographic Area in 2024
Table 35. GSK Recent Developments
Table 36. Sanofi Company Information
Table 37. Sanofi Description and Business Overview
Table 38. Sanofi Vaccines Product
Table 39. Sanofi Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Sanofi Sales Proportion of Vaccines by Product in 2024
Table 41. Sanofi Sales Proportion of Vaccines by Application in 2024
Table 42. Sanofi Sales Proportion of Vaccines by Geographic Area in 2024
Table 43. Sanofi Recent Developments
Table 44. Merck Company Information
Table 45. Merck Description and Business Overview
Table 46. Merck Vaccines Product
Table 47. Merck Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Merck Sales Proportion of Vaccines by Product in 2024
Table 49. Merck Sales Proportion of Vaccines by Application in 2024
Table 50. Merck Sales Proportion of Vaccines by Geographic Area in 2024
Table 51. Merck Recent Developments
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Vaccines Product
Table 55. Pfizer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Pfizer Sales Proportion of Vaccines by Product in 2024
Table 57. Pfizer Sales Proportion of Vaccines by Application in 2024
Table 58. Pfizer Sales Proportion of Vaccines by Geographic Area in 2024
Table 59. Pfizer Recent Developments
Table 60. Novartis(GSK) Company Information
Table 61. Novartis(GSK) Description and Business Overview
Table 62. Novartis(GSK) Vaccines Product
Table 63. Novartis(GSK) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Novartis(GSK) Sales Proportion of Vaccines by Product in 2024
Table 65. Novartis(GSK) Sales Proportion of Vaccines by Application in 2024
Table 66. Novartis(GSK) Sales Proportion of Vaccines by Geographic Area in 2024
Table 67. Novartis(GSK) Recent Developments
Table 68. CSL Company Information
Table 69. CSL Description and Business Overview
Table 70. CSL Vaccines Product
Table 71. CSL Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. CSL Sales Proportion of Vaccines by Product in 2024
Table 73. CSL Sales Proportion of Vaccines by Application in 2024
Table 74. CSL Sales Proportion of Vaccines by Geographic Area in 2024
Table 75. CSL Recent Developments
Table 76. MedImmune LLC Company Information
Table 77. MedImmune LLC Description and Business Overview
Table 78. MedImmune LLC Vaccines Product
Table 79. MedImmune LLC Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. MedImmune LLC Sales Proportion of Vaccines by Product in 2024
Table 81. MedImmune LLC Sales Proportion of Vaccines by Application in 2024
Table 82. MedImmune LLC Sales Proportion of Vaccines by Geographic Area in 2024
Table 83. MedImmune LLC Recent Developments
Table 84. J&J(Crucell) Company Information
Table 85. J&J(Crucell) Description and Business Overview
Table 86. J&J(Crucell) Vaccines Product
Table 87. J&J(Crucell) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. J&J(Crucell) Sales Proportion of Vaccines by Product in 2024
Table 89. J&J(Crucell) Sales Proportion of Vaccines by Application in 2024
Table 90. J&J(Crucell) Sales Proportion of Vaccines by Geographic Area in 2024
Table 91. J&J(Crucell) Recent Developments
Table 92. China National Biotec Company Information
Table 93. China National Biotec Description and Business Overview
Table 94. China National Biotec Vaccines Product
Table 95. China National Biotec Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. China National Biotec Sales Proportion of Vaccines by Product in 2024
Table 97. China National Biotec Sales Proportion of Vaccines by Application in 2024
Table 98. China National Biotec Sales Proportion of Vaccines by Geographic Area in 2024
Table 99. China National Biotec Recent Developments
Table 100. Tiantan Company Information
Table 101. Tiantan Description and Business Overview
Table 102. Tiantan Vaccines Product
Table 103. Tiantan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Tiantan Sales Proportion of Vaccines by Product in 2024
Table 105. Tiantan Sales Proportion of Vaccines by Application in 2024
Table 106. Tiantan Sales Proportion of Vaccines by Geographic Area in 2024
Table 107. Tiantan Recent Developments
Table 108. Hualan Company Information
Table 109. Hualan Description and Business Overview
Table 110. Hualan Vaccines Product
Table 111. Hualan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Hualan Sales Proportion of Vaccines by Product in 2024
Table 113. Hualan Sales Proportion of Vaccines by Application in 2024
Table 114. Hualan Sales Proportion of Vaccines by Geographic Area in 2024
Table 115. Hualan Recent Developments
Table 116. Kangtai Company Information
Table 117. Kangtai Description and Business Overview
Table 118. Kangtai Vaccines Product
Table 119. Kangtai Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Kangtai Sales Proportion of Vaccines by Product in 2024
Table 121. Kangtai Sales Proportion of Vaccines by Application in 2024
Table 122. Kangtai Sales Proportion of Vaccines by Geographic Area in 2024
Table 123. Kangtai Recent Developments
Table 124. Hissen Company Information
Table 125. Hissen Description and Business Overview
Table 126. Hissen Vaccines Product
Table 127. Hissen Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Hissen Sales Proportion of Vaccines by Product in 2024
Table 129. Hissen Sales Proportion of Vaccines by Application in 2024
Table 130. Hissen Sales Proportion of Vaccines by Geographic Area in 2024
Table 131. Hissen Recent Developments
Table 132. Jintan Company Information
Table 133. Jintan Description and Business Overview
Table 134. Jintan Vaccines Product
Table 135. Jintan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Jintan Sales Proportion of Vaccines by Product in 2024
Table 137. Jintan Sales Proportion of Vaccines by Application in 2024
Table 138. Jintan Sales Proportion of Vaccines by Geographic Area in 2024
Table 139. Jintan Recent Developments
Table 140. North America Vaccines Sales by Country (2020-2025) & (K Units)
Table 141. North America Vaccines Sales by Country (2026-2031) & (K Units)
Table 142. North America Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 143. North America Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 144. North America Vaccines Sales by Type (2020-2025) & (K Units)
Table 145. North America Vaccines Sales by Application (2020-2025) & (K Units)
Table 146. Asia-Pacific Vaccines Sales by Region (2020-2025) & (K Units)
Table 147. Asia-Pacific Vaccines Sales by Region (2026-2031) & (K Units)
Table 148. Asia-Pacific Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 149. Asia-Pacific Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 150. Asia-Pacific Vaccines Sales by Type (2020-2025) & (K Units)
Table 151. Asia-Pacific Vaccines Sales by Application (2020-2025) & (K Units)
Table 152. Europe Vaccines Sales by Country (2020-2025) & (K Units)
Table 153. Europe Vaccines Sales by Country (2026-2031) & (K Units)
Table 154. Europe Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 155. Europe Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 156. Europe Vaccines Sales by Type (2020-2025) & (K Units)
Table 157. Europe Vaccines Sales by Application (2020-2025) & (K Units)
Table 158. Latin America Vaccines Sales by Country (2020-2025) & (K Units)
Table 159. Latin America Vaccines Sales by Country (2026-2031) & (K Units)
Table 160. Latin America Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 161. Latin America Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 162. Latin America Vaccines Sales by Type (2020-2025) & (K Units)
Table 163. Latin America Vaccines Sales by Application (2020-2025) & (K Units)
Table 164. Middle East and Africa Vaccines Sales by Country (2020-2025) & (K Units)
Table 165. Middle East and Africa Vaccines Sales by Country (2026-2031) & (K Units)
Table 166. Middle East and Africa Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 167. Middle East and Africa Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 168. Middle East and Africa Vaccines Sales by Type (2020-2025) & (K Units)
Table 169. Middle East and Africa Vaccines Sales by Application (2020-2025) & (K Units)
Table 170. Vaccines Key Raw Materials, Industry Status and Trend
Table 171. Vaccines Key Raw Materials and Upstream Suppliers
Table 172. Vaccines Clients Status and Trend
Table 173. Vaccines Typical Clients
Table 174. Vaccines Distributors
Table 175. Vaccines Market Trends
Table 176. Vaccines Market Drivers
Table 177. Vaccines Market Challenges
Table 178. Vaccines Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
Table 182. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Vaccines Product Picture
Figure 2. Global Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. Recombinant Vaccines Product Picture
Figure 5. Viral Vaccines Product Picture
Figure 6. Polysaccharide Vaccines Product Picture
Figure 7. Others Product Picture
Figure 8. Global Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Vaccines Sales Market Share by Application in 2024 & 2031
Figure 10. Rabies vaccine
Figure 11. Influenza vaccine
Figure 12. HPV vaccine
Figure 13. Hepatitis B
Figure 14. Hepatitis A
Figure 15. Leprosy vaccine
Figure 16. Polio vaccine
Figure 17. JE vaccine
Figure 18. Others
Figure 19. Vaccines Report Years Considered
Figure 20. Global Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Vaccines Market Size 2020-2031 (US$ Million)
Figure 22. Global Vaccines Sales 2020-2031 (K Units)
Figure 23. Global Vaccines Sales Market Share Forecast by Region (2020-2031)
Figure 24. Global Vaccines Revenue Market Share by Region (2020-2031)
Figure 25. Global Vaccines Sales Market Share Forecast by Type (2020-2031)
Figure 26. Global Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 27. Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 28. Global Vaccines Sales Market Share Forecast by Application (2020-2031)
Figure 29. Global Vaccines Revenue Market Share Forecast by Application (2020-2031)
Figure 30. Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 31. Recombinant Vaccines of Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 32. Viral Vaccines of Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 33. Polysaccharide Vaccines of Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 34. Others of Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 35. Global Vaccines Sales Share by Manufacturer in 2024
Figure 36. Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Recombinant Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 38. Viral Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 39. Polysaccharide Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 40. Others Market Sales Proportion by Manufacturer in 2024
Figure 41. North America Vaccines Revenue 2020-2031 (US$ Million)
Figure 42. North America Vaccines Sales Market Share by Type (2020-2025)
Figure 43. North America Vaccines Sales Market Share by Application (2020-2025)
Figure 44. Asia-Pacific Vaccines Revenue 2020-2031 (US$ Million)
Figure 45. Asia-Pacific Vaccines Sales Market Share by Region (2020-2031)
Figure 46. Asia-Pacific Vaccines Revenue Market Share by Region (2020-2031)
Figure 47. Asia-Pacific Vaccines Sales Market Share by Type (2020-2025)
Figure 48. Asia-Pacific Vaccines Sales Market Share by Application (2020-2025)
Figure 49. Europe Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Europe Vaccines Sales Market Share by Country (2020-2031)
Figure 51. Europe Vaccines Revenue Market Share by Country (2020-2031)
Figure 52. Europe Vaccines Sales Market Share by Type (2020-2025)
Figure 53. Europe Vaccines Sales Market Share by Application (2020-2025)
Figure 54. Latin America Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 55. Latin America Vaccines Sales Market Share by Country (2020-2031)
Figure 56. Latin America Vaccines Revenue Market Share by Country (2020-2025)
Figure 57. Latin America Vaccines Sales Market Share by Type (2020-2025)
Figure 58. Latin America Vaccines Sales Market Share by Application (2020-2025)
Figure 59. Middle East and Africa Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 60. Middle East and Africa Vaccines Sales Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Vaccines Revenue Market Share by Country (2020-2031)
Figure 62. Middle East and Africa Vaccines Sales Market Share by Type (2020-2025)
Figure 63. Middle East and Africa Vaccines Sales Market Share by Application (2020-2025)
Figure 64. Vaccines Supply Chain (Upstream and Downstream Market)
Figure 65. Global Production Market Share of Vaccines Raw Materials by Region in 2024
Figure 66. Vaccines Distribution Channels
Figure 67. Global Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 68. Global Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232